In the context of mice with ALS, researchers propose that the TrkB.T1 deletion acts as an “LTP desaturation” strategy because receptor TrkB.T1 does not alter LTP under physiological conditions [40]. Here, NTRK2 is linked to amyotrophic lateral sclerosis.